#Urology Devices Market Growth

[healthcaremarketanalysis]

Urology Devices Market worth $48.6 billion by 2028

Urology Devices Market in terms of revenue was estimated to be worth $34.1 billion in 2023 and is poised to reach $48.6 billion by 2028, growing at a CAGR of 7.3% from 2023 to 2028 according to a new report by MarketsandMarkets. The high prevalence of urological diseases significantly impacts the increased demand for urological devices. Cancer patients who need surgical interventions with latest technologies like minimally invasive surgery and robotic surgeries. This will lead to an increased need for urological devices. Thus, the escalating demand for urological disease diagnosis and treatment, has led to a pressing need for technologically advanced devices, which is thereby expected to support the growth of the urological devices market.

Download an Illustrative overview:

Browse in-depth TOC on "Urology Devices Market"

159 - Tables

44 - Figures

274 – Pages

In 2022, the instruments segment held the largest share of the urology devices market by product segment.

The urology devices market is segmented into instruments and consumables & accessories based on products. The instruments segment accounted for the largest share of the urology devices market in 2022. This segment covers the most commonly used products, such as dialysis devices, endoscopes, laser & lithotripsy devices, endovision & imaging systems, robotic systems, insufflators, endoscopy fluid management systems, urodynamic systems and other instruments. These products are commonly used in hospitals, dialysis centers and home care settings. As technologies continue to evolve, the efficiency and accuracy of these products contribute significantly to the urological procedures.

The kidney diseases segment held the largest share of the urology devices market by application segment in 2022.

The global urology devices market is differentiated into kidney diseases, urological cancer, pelvic organ prolapse, benign prostatic hyperplasia, urinary incontinence, erectile dysfunction, urinary stones and other applications. In 2022, the kidney diseases segment dominated the urology devices market. The urology devices market in kidney diseases is expected to grow at a high rate owing to the rising incidence of kidney diseases and chronic diseases. With a burgeoning global population, the need for urology devices has significantly increased due to the increased number of procedures required. Hospitals and dialysis centers are at the forefront of this surge, as they cater to routine medical care and handle emergencies.

The hospitals, ASCA & clinics segment held the largest share of the urology devices market by end-user segment in 2022.

The global urology devices market is differentiated into hospitals, ASCS & clinics, dialysis centers and home care settings. In 2022, the hospitals, ASCS & clinics segment dominated the urology devices market. The urology devices market in hospitals is expected to grow at a high rate owing to the increasing number of surgical procedures related to urology care. The expanding network of healthcare institutions directly translates to a substantial market share, reflecting the pivotal role hospitals play in safeguarding patient well-being.

North America is the largest regional market for urology devices market.

The market for urology devices has been divided into five key geographical regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2022, North America held the predominant portion of the urology devices market. This can be attributed to the region's advanced healthcare facilities and substantial healthcare investments, which are pivotal in fueling the requirement for urology devices. Moreover, the projected rise in urological procedures is anticipated to contribute to the expansion of the market. As the demand for urological procedures rises, so does the need for precise urological devices to ensure successful and safe procedures.

Request Sample Pages:

Urology Devices Market Dynamics:

Drivers:

Rising incidence of urological diseases

Growing preference for minimally invasive procedures

Rising focus on R&D and product launches

Growing number of hospitals and surgical centers

Restraints:

High degree of consolidation among key players

Opportunities:

Growing Potential growth opportunities in emerging economies

Technological advancements

Challenge:

Increasing number of product recalls by key players

Shortage of skilled urologists

Key Market Players of Urology Devices Industry:

The major players operating in urology devices market are Fresenius Medical Care AG & Co. KGaA (Germany), Baxter International, Inc. (US), Boston Scientific Corporation (US), Becton, Dickinson and Company (US), B. Braun Melsungen AG (Germany), Cardinal Health (US), Olympus Corporation (Japan), Intuitive Surgical (US), Coloplast A/S (Denmark), Stryker Corporation (US), Teleflex Incorporated (US), Convatec Group PLC (UK), Medtronic PLC (Ireland), Karl Storz (Germany), Cook Medical (US), Richard Wolf GmbH (Germany), CompactCath (US), Dornier MedTech (Germany), Nikkiso Co., Ltd. (Japan), Dialife SA (Switzerland), Erbe Vision (Germany), Well Lead Medical Co., Ltd. (China), ROCAMED (Germany), EndoMed Systems GmbH (Germany), Amniso International, Inc. (US), Medispec (US), Medical Technologies of Georgia (US), Vimex Sp. z o.o. (Poland), Balton Sp. z o.o. (Poland), Hunter Urology (UK), Ribbel International Ltd. (India).

Recent Developments of Urology Devices Industry

In August 2023, Fresenius Medical Care AG & Co. KGaA (Germany), announced FDA Clearance for the product Versi HD with GuideMe Software.

In December 2022, Boston Scientific Corporation (US) and Acotec Scientific Holdings Limited (China) announced today that Boston Scientific will make a partial offer to acquire a majority stake, up to a maximum of 65%, of shares of Acotec, a Chinese medical technology company that offers solutions designed for a variety of interventional procedures.

In May 2022, B. Braun SE (Germany) entered into a distribution agreement, and B. Braun surgery division Aesculap has strengthened its long-term partnership with True Digital Surgery, a Californian company that is an expert in robotically controlled 3D digital visualization.

In April 2022, Baxter International, Inc. (US) Announces U.S. FDA Clearance of ST Set used for renal replacement therapy (CRRT)

In April 2021, Becton, Dickinson and Company (US) announced an investment of USD 65 million for the construction of a state-of-the-art medical facility in Tucson, Arizona (US), which will serve as a final stage manufacturing and sterilization center to improve overall efficiency, customer service, and supply chain in the US.

Urology Devices Market - Key Benefits of Buying the Report:

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall urology devices market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, opportunities and challenges.

The report provides insights on the following pointers:

Analysis of key drivers (Rising incidence of urological diseases, growing preference for minimally invasive procedures, rising focus on R&D and product launches, growing number of hospitals and surgical centers), restraints (high degree of consolidation among key players), opportunities (potential growth opportunities in emerging economies, technological advancements) and challenges (increasing number of product recalls by key players, shortage of skilled urologists) influencing the growth of the urology devices market.

Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the urology devices market.

Market Development: Comprehensive information about lucrative markets – the report analyses the urology devices market across varied regions.

Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the urology devices market

Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players like Fresenius Medical Care AG & Co. KGaA (Germany), Baxter International, Inc. (US), Boston Scientific Corporation (US), Becton, Dickinson and Company (US), B. Braun Melsungen AG (Germany), among others in the urology devices market strategies.

[mitalipingale]

https://carbonfacesocial.org/blogs/69733/Urology-Devices-Market-Size-Overview-Share-and-Forecast-2031

The Urology Devices Market in 2023 is US$ 41.35 billion, and is expected to reach US$ 58 billion by 2031 at a CAGR of 4.30%.

[mrfr-blogs]

Navigating the Dynamics of Urology Devices Market Industry

Market Overview –

The Urology Devices Market encompasses medical devices and equipment used in the diagnosis, treatment, and management of urological disorders and conditions affecting the urinary tract and male reproductive system. This includes devices for urinary incontinence, kidney stones, benign prostatic hyperplasia (BPH), urinary tract infections (UTIs), erectile dysfunction, and other urological conditions.

One significant driver of the Urology Devices Market's growth is the increasing prevalence of urological disorders worldwide, driven by factors such as aging demographics, lifestyle changes, and the rising incidence of chronic diseases such as diabetes and hypertension. As the population ages, the demand for urology devices for conditions such as urinary incontinence, BPH, and kidney stones is expected to rise.

Advancements in urological procedures and minimally invasive surgical techniques have also fueled market growth by expanding the scope of treatment options available to patients. Urology devices such as catheters, stents, lithotripters, and robotic surgical systems enable healthcare providers to perform complex procedures with greater precision, reduced recovery times, and improved patient outcomes.

Moreover, the increasing awareness of urological health and the availability of advanced diagnostic and treatment options have led to greater patient demand for urology devices and services. As healthcare systems prioritize preventive care and early intervention, the Urology Devices Market is expected to continue growing, offering opportunities for innovation and investment in medical device technology.

The Urology Devices Market is witnessing steady growth, driven by rising urological disorders and technological advancements in medical devices. Urology devices such as catheters, stents, and endoscopes are vital in diagnosing and treating urinary tract conditions. With a growing aging population and increasing awareness, the demand for urology devices continues to escalate.

The urological devices market was valued at USD 36.5 billion in 2022 and is expected to rise from USD 37.96 billion in 2023 to USD 48.5 billion by 2032, with a compound annual growth rate (CAGR) of 4% between 2023 and 2032.

Market Segmentation –

The global Urology Devices market has been segmented based on Type, Application, Technology and End-User.

On the basis of Type, the market is segmented into dialysis equipment, urinary stone treatment devices, endoscopy devices, benign prostatic hyperplasia treatment devices, and urinary incontinence & pelvic organ prolapse. The market revenue for urology devices was dominated by endoscopic devices in 2022, which can be ascribed to the rising prevalence of urolithiasis and the strong demand for disposable cystoscopes, particularly in developed nations.

Based on Application, the global Urology Devices market has been segmented into Minimally Invasive Surgery and Robotic Surgery. In 2022, the minimally invasive surgery category dominated the industry. According to projections, the terminal side segment will experience the largest growth between 2023 and 2030, with an increase in urological problem patients choosing minimally invasive procedures over more invasive ones.

Based on Technology, the global Urology Devices market has been segmented into benign prostatic hyperplasia, prostate cancer, urinary stones, and urinary incontinence. Due to the higher risk of developing urine incontinence in diabetic patients, the urinary incontinence Urology Devices category had the majority share of the market revenue for Urology Devices in 2022.

Based on End-User, the global Urology Devices market has been segmented into hospitals and ambulatory services. Due to the increasing number of patient visits at hospitals for urology-related illnesses, the hospitals and clinics segment, which held the market's top spot in 2022, is anticipated to grow at the fastest rate throughout the forecast period, 2023-2030.

Regional Analysis –

The regional analysis of the urology devices market reveals varying dynamics influenced by factors such as healthcare infrastructure development, prevalence of urological disorders, and regulatory frameworks. North America dominates the market, driven by the high prevalence of conditions like urinary incontinence and kidney stones, coupled with advanced medical technology adoption. Europe follows suit, with increasing investments in urology devices and rising demand for minimally invasive procedures. In the Asia-Pacific region, improving access to healthcare services, growing aging population, and increasing awareness about urological health contribute to market growth. Developing regions in Latin America and Africa are also witnessing gradual market expansion as healthcare infrastructure improves and awareness about urological disorders increases.

Key Players –

Urology devices companies include KARL STORZ GmbH & Co. KG, Olympus Corporation, Medtronic, Boston Scientific Corporation, R. Bard, Fresenius Medical Care AG & Co. KGaA (Germany), Dornier MedTech (Germany), and Stryker (US)

Related Reports –

US Melanoma

Middle East and Africa HIV Diagnosis & Treatment

Gastroparesis Treatment

Dental Infection Treatment

For more information visit at MarketResearchFuture

[marketsndata]

Saudi Arabia Medical Lasers Market Analysis 2030

Saudi Arabia Medical Lasers Market was valued at USD 100.2 million in 2022 and is expected to reach USD 236.6 million in 2030 with a CAGR of 11.34% for the forecast period between 2023 and 2030. The medical lasers market in Saudi Arabia has been experiencing significant growth and technological advancements. Medical lasers are specialized devices used in various medical procedures to perform precise and minimally invasive treatments, making them a sought-after technology in the healthcare industry. The increasing prevalence of chronic diseases, rising demand for non-invasive treatment options, and a growing healthcare infrastructure have been major drivers for the medical lasers market in Saudi Arabia. 

Moreover, the country’s aging population has further fueled the need for advanced medical technologies like lasers. Saudi Arabia’s government has been actively investing in the healthcare sector, supporting the adoption of innovative medical technologies such as medical lasers. This commitment has facilitated the introduction of state-of-the-art laser systems in hospitals and clinics nationwide.

The increasing range of medical applications of lasers has also driven the market. Medical professionals increasingly use lasers in dermatology for skin treatments, in ophthalmology for vision correction surgeries, in dentistry for various oral procedures, and in oncology for cancer treatments. Advancements in laser technology have improved their efficiency, safety, and versatility. Laser systems with better precision and reduced side effects have garnered the attention of healthcare providers and patients alike. As the demand for minimally invasive treatment options continues to rise, the market is expected to expand further, providing better healthcare outcomes for patients in the region. 

Increasing Demand for Aesthetic Procedures

There has been a significant increase in the demand for aesthetics-related medical laser treatments in Saudi Arabia. Aesthetic procedures utilizing medical lasers, such as laser hair removal, skin rejuvenation, tattoo removal, and body contouring, have gained popularity among men and women seeking non-invasive cosmetic enhancements. The rise in demand can be attributed to several factors. First, there is a growing awareness of aesthetic procedures and their positive impact on self-confidence and appearance. Second, the cultural shift towards accepting cosmetic enhancements to maintain youthful looks has increased interest in medical laser treatments. Advancements in laser technology have led to safer, more effective, and less painful aesthetic procedures, reducing the associated downtime. Additionally, specialized aesthetic clinics and well-trained healthcare professionals offering these services have played a crucial role in meeting the rising demand.

During February 2020, Sisram Medical Ltd (Alma Lasers) introduced ClearSkin PRO, an innovative applicator with twice the power of its predecessors, providing noticeable improvements in the appearance of skin, leading to a more youthful look.

Progress in the field of Urology

Saudi Arabia has witnessed significant progress and advancements, particularly in applying medical lasers to the field of Urology. The Saudi Arabia medical laser market has experienced notable growth as cutting-edge laser technologies are increasingly adopted in urological procedures. Medical lasers have revolutionized urological treatments by offering minimally invasive solutions for various conditions, such as kidney stones, benign prostatic hyperplasia (BPH), and urological cancers. The precise and targeted nature of laser technology has led to reduced complications, shorter recovery times, and improved patient outcomes. The Saudi Arabian healthcare system’s commitment to investing in advanced medical technologies has facilitated the integration of lasers into urological practice. This progress has been supported by collaborations between healthcare institutions and medical device manufacturers, leading to the continuous refinement and development of laser-based urological treatments.

In July 2021, Lumenis introduced a comprehensive worldwide education platform, MOSES HoLEP University. This platform enables urologists to offer patients state-of-the-art treatment for benign prostatic hyperplasia (BPH) called formium laser enucleation (HoLEP) of the prostate using the innovative MOSES technology. The MOSES HoLEP University equips urologists with the necessary knowledge and skills to perform this advanced procedure, which has been established as the gold standard for treating BPH.

Surge in Surgical Interventions

The Saudi Arabia medical lasers market has witnessed a notable increase in surgical procedures. This upsurge can be attributed to several factors driving the demand for medical lasers in the country. Firstly, a growing population with rising healthcare needs has increased the prevalence of chronic diseases and age-related conditions, necessitating more surgical interventions. Advancements in medical technology and innovative surgical techniques have bolstered the confidence of healthcare practitioners and patients, leading to a greater willingness to opt for surgical treatments.

Additionally, the government’s efforts to improve healthcare infrastructure and increase access to medical facilities across the country have contributed to the rise in surgical procedures. The growing awareness among the population regarding the availability and benefits of modern medical devices has fuelled the demand for such procedures. As the healthcare sector in Saudi Arabia continues to evolve and cater to the increasing healthcare demands, the trend of rising surgical procedures is expected to persist in the foreseeable future.

Technological Advancements

Saudi Arabia has witnessed remarkable technological advancement in the Medical Lasers market. Innovations in laser technology have revolutionized medical procedures, offering precise and minimally invasive solutions for various healthcare applications. One significant area of advancement is in the field of dermatology and aesthetics. Advanced medical lasers have enabled the treatment of skin conditions, such as acne, pigmentation, and scars, with higher precision and reduced downtime. Moreover, introducing fractional lasers has allowed safer and more effective skin resurfacing procedures. In addition to dermatology, medical lasers have also transformed surgical practices. Laser-assisted surgeries have gained popularity because they provide better tissue targeting, reduced bleeding, and faster recovery times. Medical lasers have become integral to various specialties from ophthalmology to gynecology and urology. Advancements in laser technology have also expanded into the realm of non-invasive treatments for chronic pain management and physical therapy. Low-level laser therapy has shown promising results in accelerating tissue repair and reducing inflammation.

In Saudi Arabia, Imdad provides a range of products, including Lutronic’s eCO2 plus, a fractional ablative CO2 laser designed for scar and laxity improvement. It utilizes a 120 µ tip to achieve deep fractional ablation. Additionally, Candela Medical offers Picoway, a pico-second laser with a pulse duration of 450 PS, making it ideal for skin resurfacing.

Impact of COVID-19

The COVID-19 pandemic has significantly impacted the Saudi Arabia medical lasers market. While initial disruption was due to lockdowns and reduced elective procedures, the market gradually recovered with the resumption of healthcare services. The increased adoption of telemedicine and remote consultations during the pandemic led to a surge in demand for laser-based treatments that can be administered with minimal contact. The growing focus on hygiene and infection control measures also bolstered the preference for laser procedures over traditional methods.

Following the severe impact of COVID-19 on the market, a noticeable shift occurred post-2021, with the pandemic under control. This shift was characterized by an increasing trend in aesthetic procedures, driven by a heightened emphasis on appearance among the general population. According to a research study conducted by Abdulaziz K. Alhujayri et al. and published in Plastic and Reconstructive Surgery Global Open Journal in June 2021, there were great disparities in the engagement and perception of cosmetic procedures among the Saudi Arabian population during the COVID-19 pandemic. The study revealed that approximately 49.7% of the population cited fear of contracting the virus as a significant factor that deterred them from undergoing cosmetic procedures throughout the pandemic.

Download Free Sample Report

Saudi Arabia Medical Lasers Market: Report Scope

Saudi Arabia Medical Lasers Market Assessment, Opportunities and Forecast, 2016-2030”, is a comprehensive report by Markets and Data, providing in-depth analysis and qualitative & and quantitative assessment of the current state of the Medical Lasers market, industry dynamics and challenges. The report includes market size, segmental shares, growth trends, COVID-19, opportunities, and forecasts between 2023 and 2030F. Additionally, the report profiles the leading players in the industry, mentioning their respective market share, business models, competitive intelligence, etc.

Click here for full report- https://www.marketsandata.com/industry-reports/saudi-arabia-medical-lasers-market

Latest reports-

Contact

Mr. Vivek Gupta 5741 Cleveland street, Suite 120, VA beach, VA, USA 23462 Tel: +1 (757) 343–3258 Email: info@marketsandata.com Website: https://www.marketsandata.com

[surbhijamdade]

Global Laparoscopy Devices Market Report: Insights, Trends, and Key Players

Straits Research, a leading provider of business intelligence, is pleased to announce the release of its latest report on the global Laparoscopy Devices Market. This comprehensive report provides valuable insights into market size, growth drivers, key developments, and major players, offering essential information for stakeholders and industry participants.

Request a Sample Report of Laparoscopy Devices Market

Market Size

The global Laparoscopy Devices Market was valued at USD 27.17 billion in 2024 and is projected to grow significantly, reaching USD 49.95 billion by 2033. This growth represents a compound annual growth rate (CAGR) of 7% during the forecast period from 2025 to 2033. The increasing adoption of minimally invasive surgical procedures and advancements in laparoscopic technologies are key factors driving this market expansion.

Drivers in the Laparoscopy Devices Market

Several factors are contributing to the growth of the Laparoscopy Devices Market:

• Rising Demand for Minimally Invasive Surgeries: Patients and healthcare providers are increasingly opting for minimally invasive procedures due to their benefits, such as reduced recovery time, lower risk of complications, and shorter hospital stays. • Technological Advancements: Continuous innovations in laparoscopic devices, including high-definition imaging systems, robotic-assisted surgery systems, and advanced energy devices, are enhancing the efficiency and outcomes of laparoscopic surgeries. • Growing Prevalence of Chronic Diseases: The increasing incidence of chronic conditions, such as obesity, colorectal cancer, and gynecological disorders, is driving the demand for laparoscopic interventions. • Favorable Reimbursement Policies: Supportive reimbursement frameworks in various regions are encouraging the adoption of laparoscopic procedures.

Key Developments in the Laparoscopy Devices Market

The Laparoscopy Devices Market is witnessing several key developments:

• Integration of Artificial Intelligence (AI): AI-powered laparoscopic systems are being developed to assist surgeons in decision-making, improving precision and reducing the risk of errors. • Enhanced Imaging Technologies: The introduction of 4K and 3D imaging systems is providing surgeons with clearer and more detailed views during procedures, leading to better surgical outcomes. • Robotic-Assisted Surgery: The adoption of robotic-assisted laparoscopic systems is increasing, offering greater dexterity and control to surgeons, especially in complex procedures. • Sustainability Initiatives: Companies are focusing on developing eco-friendly laparoscopic devices and packaging to reduce environmental impact.

Request a Sample Report of Laparoscopy Devices Market

Top Key Players

The Laparoscopy Devices Market is highly competitive, with several key players leading the industry:

1.B. Braun Melsungen AG 2.ConMed Corporation 3.Boston Scientific Corporation 4.Johnson and Johnson 5.Medtronic Plc. (Covidien) 6.Karl Storz SE and CO. KG 7.Richard Wolf GmbH 8.Olympus Corporation 9.Stryker Corporation

These companies are at the forefront of the Laparoscopy Devices Market, offering a wide range of innovative products and solutions to meet the growing demand for laparoscopic procedures.

Segmentation Analysis of the Laparoscopy Devices Market

The market is segmented based on product type, applications, and end-user:

By Product Type: • Laparoscopes • Energy Devices • Insufflators • Robot-Assisted Surgery Systems • Suction or Irrigation Systems • Closure Devices • Hand Instruments • Access Devices • Accessories • Others

By Applications: • General Surgery • Bariatric Surgery • Gynecological Surgery • Urological Surgery • Colorectal Surgery • Others

By End-User: • Hospitals • Clinics • Others

Buy Laparoscopy Devices Market Report here!

About Straits Research

Straits Research is a top provider of business intelligence, specializing in research, analytics, and advisory services. We focus on delivering in-depth insights through comprehensive reports, helping businesses make informed decisions and achieve sustainable growth.

Contact Us:

Email: sales@straitsresearch.com Address: 825 3rd Avenue, New York, NY, USA, 10022 Phone: +1 646 905 0080 (US), +91 8087085354 (India), +44 203 695 0070 (UK) For more information about the Laparoscopy Devices Market report, please visit our website or contact us directly.

[blueweave]

 Saudi Arabia Disposable Endoscopy Market size by value at USD 486.9 million in 2023.During the forecast period between 2024 and 2030, BlueWeave expects Saudi Arabia Disposable Endoscopy Market size to expand at a CAGR of 5.60% reaching a value of USD 716.8 million by 2030. Saudi Arabia Disposable Endoscopy Market is driven by the rising prevalence of gastrointestinal, respiratory, and urological diseases, coupled with the growing demand for minimally invasive procedures. Increasing healthcare investments and the adoption of advanced technologies in hospitals and clinics further boost market growth. Disposable endoscopes reduce cross-contamination risks, aligning with stringent infection control policies. Additionally, the expanding medical tourism sector and an aging population contribute to the increasing demand for efficient, safe, and cost-effective endoscopy solutions.

Sample Request: https://www.blueweaveconsulting.com/report/saudi-arabia-disposable-endoscopy-market/report-sample

Opportunity – Continuous Advancements in Endoscopy Technology

Saudi Arabia Disposable Endoscopy Market is witnessing growth due to continuous technological advancements in endoscopy. Innovations, such as high-definition imaging, improved optical systems, and enhanced disposable endoscopic devices, are addressing infection control challenges while improving diagnostic accuracy. These advancements align with the country's focus on healthcare modernization under Vision 2030. Additionally, the integration of AI and robotics into endoscopy supports minimally invasive procedures, increasing adoption among healthcare providers and driving demand for disposable endoscopy solutions.

[industrynewsupdates]

An In-Depth Look at the Growth of Global Surgical Robots Market

The global surgical robots market size is expected to reach USD 7.42 billion by 2030 and is expected to grow at a CAGR of 9.5% from 2024 to 2030, according to a new report by Grand View Research, Inc. Surgical robotic systems are equipped with high-definition cameras and robotic arms, allowing surgeons to perform complicated procedures with enhanced accuracy. The market has grown substantially due to rising demand for minimally invasive surgeries, need for improved surgical outcomes, and continuous evolution of robotic technology. As the healthcare landscape embraces innovation, surgical robots are increasingly becoming a vital tool, revolutionizing surgical approaches and contributing to better patient care.

Moreover, increasing penetration of international players in various regions is expected to boost market growth. COVID-19 outbreak significantly influenced the uptake and integration of surgical robots. Supply chain disruptions and extensive lockdowns across key nations had a notable impact on market growth. An overall decline in surgical procedure volumes due to the pandemic and stringent regulations contributed to the downturn in 2020. As circumstances move closer to pre-pandemic norms, the market is poised for substantial growth.

Gather more insights about the market drivers, restrains and growth of the Surgical Robots Market

Surgical Robots Market Report Highlights

• Based on application, others segment accounted for a revenue share of 44.6% in 2023 due to increased usage of advanced automated instruments in cancer and high demand for minimally invasive laparoscopic surgeries

• Based on end-use, inpatient facilities segment held the largest revenue share of 53.21% in 2023 due to high financial resources and patient volume to justify the investment in costly surgical robotic systems

• North America accounted for the largest revenue share of 49.9% in 2023, owing to the strong presence of international players, a lineup of several U.S. FDA clearance products, ongoing robotics developments, and demand for minimally invasive surgeries to reduce the post-operative period

Browse through Grand View Research's Medical Devices Industry Research Reports.

• The global ophthalmic sutures market size was estimated at USD 467.3 million in 2024 and is projected to grow at a CAGR of 7.2% from 2025 to 2030.

• The global irradiation apparatus market size was estimated at USD 7.89 billion in 2024 and is expected to grow at a CAGR of 6.0% from 2025 to 2030.

Surgical Robots Market Segmentation

Grand View Research has segmented the global surgical robots market based on application, end-use, and region:

Surgical Robots Application Outlook (Revenue, USD Million, 2018 - 2030)

• Orthopedics

o Knee

o Hip

o Spine

o Others

• Neurology

• Urology

• Gynecology

• Others

Surgical Robots End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Inpatient

• Outpatient

Surgical Robots Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

o U.S.

o Canada

• Europe

o UK

o Germany

o Italy

o France

o Spain

o Denmark

o Sweden

o Norway

• Asia-Pacific

o China

o Japan

o India

o Australia

o South Korea

o Thailand

• Latin America

o Brazil

o Mexico

o Argentina

• Middle East & Africa

o South Africa

o Saudi Arabia

o UAE

o Kuwait

Order a free sample PDF of the Surgical Robots Market Intelligence Study, published by Grand View Research.

[healthcaremarketanalysis]

Urology Devices Market in terms of revenue was estimated to be worth $34.1 billion in 2023 and is poised to reach $48.6 billion by 2028, growing at a CAGR of 7.3% from 2023 to 2028 according to a new report by MarketsandMarkets. The high prevalence of urological diseases significantly impacts the increased demand for urological devices. Cancer patients who need surgical interventions with latest technologies like minimally invasive surgery and robotic surgeries. This will lead to an increased need for urological devices. Thus, the escalating demand for urological disease diagnosis and treatment, has led to a pressing need for technologically advanced devices, which is thereby expected to support the growth of the urological devices market.

[credenceresearchdotblog]

The Deflectable Catheters Market is projected to grow from USD 1,931.5 million in 2024 to USD 2,782.73 million by 2032, with a compound annual growth rate (CAGR) of 4.67%.The global healthcare sector is witnessing rapid advancements in medical devices, driven by technological innovations and the growing need for minimally invasive procedures. One such device gaining traction is the deflectable catheter, a highly specialized tool used in various medical fields such as cardiology, neurology, and urology. This article explores the current state of the deflectable catheters market, highlighting its key drivers, trends, challenges, and future prospects.Deflectable catheters are flexible tubes designed to navigate complex anatomical structures with precision. These catheters are equipped with steerable tips, allowing healthcare professionals to access hard-to-reach areas with greater control during diagnostic and therapeutic procedures. Their versatility makes them essential in treatments such as electrophysiology studies, cardiac ablations, and vascular interventions.

Browse the full report https://www.credenceresearch.com/report/deflectable-catheters-market

Market Overview

The deflectable catheters market has experienced steady growth over the past decade, fueled by the rising prevalence of chronic diseases, particularly cardiovascular and neurological disorders. According to recent estimates, cardiovascular diseases remain the leading cause of death globally, creating a substantial demand for advanced medical devices like deflectable catheters.

Key Market Drivers

1. Rising Prevalence of Chronic Diseases Chronic conditions such as arrhythmias, stroke, and cancer have led to an increased adoption of minimally invasive procedures, where deflectable catheters play a pivotal role.

2. Technological Advancements Innovations in catheter design, such as improved tip deflection mechanisms and integration with imaging technologies, have enhanced their precision and efficiency.

3. Growing Aging Population The aging population is more susceptible to chronic diseases, driving the demand for advanced therapeutic and diagnostic tools.

4. Expanding Healthcare Infrastructure Emerging markets, particularly in Asia-Pacific and Latin America, are witnessing significant investments in healthcare, creating opportunities for the adoption of advanced medical devices.

Current Trends

1. Increased Focus on Electrophysiology Electrophysiology, a field dedicated to diagnosing and treating electrical activities in the heart, has seen a surge in procedures using deflectable catheters.

2. Integration with Robotics Robotic-assisted interventions using deflectable catheters offer enhanced precision and reduced procedural risks, representing a transformative trend in the market.

3. Use of Biocompatible Materials The shift towards catheters made from biocompatible materials minimizes adverse reactions, improving patient outcomes.

4. Emergence of Disposable Catheters The growing emphasis on reducing cross-contamination has boosted the demand for single-use, disposable catheters.

Challenges in the Market

Despite its promising growth, the deflectable catheters market faces several challenges:

1. High Cost of Devices Advanced deflectable catheters are expensive, limiting their accessibility, particularly in low- and middle-income countries.

2. Stringent Regulatory Requirements The approval process for medical devices is rigorous and time-consuming, posing a barrier for manufacturers.

3. Risk of Complications Although minimally invasive, procedures involving catheters carry risks such as infections, perforations, and device failures, which can deter adoption.

4. Skilled Workforce Shortage The use of deflectable catheters requires specialized training, and a lack of skilled healthcare professionals can hinder market growth.

Future Prospects

The deflectable catheters market is poised for significant growth in the coming years. Factors contributing to this growth include:

Expansion of AI and Imaging Integration Artificial intelligence (AI) is expected to play a critical role in real-time imaging and navigation, making procedures more accurate and efficient.

Focus on Customization Manufacturers are increasingly offering customizable solutions tailored to specific medical conditions and patient needs.

Rising Investments in R&D Continuous investments in research and development are expected to lead to innovative product offerings.

Market Penetration in Emerging Economies The increasing focus on improving healthcare access in emerging markets will further drive demand for deflectable catheters.

Key Player Analysis

Medtronic Plc.

Boston Scientific Corporation

Abbott

Biosense Webster Inc.

Teleflex Incorporated

Biotronik SE & Co. KG.

Merit Medical Systems

OSYPKA AG

Biomerics LLC

Japan Lifeline Co.

CathRx Ltd.

Segments:

Based on Product Type:

Uni-Directional Deflectable Catheters

Bi-Directional Deflectable Catheters

Multi-Directional Deflectable Catheters

Based on Application:

Deflectable Catheters for Coronary Interventions

Deflectable Catheters for Electrophysiology

Deflectable Catheters for Diagnostics Imaging

Deflectable Catheters for Peripheral Interventions

Based on End User:

Deflectable Catheters for Hospitals

Deflectable Catheters for Office-based Clinics

Deflectable Catheters for Ambulatory Surgical Centres

Deflectable Catheters for Independent Catheterization Labs

Based on the Geography:

North America

U.S.

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Spain

Rest of Europe

Asia Pacific

China

Japan

India

South Korea

South-east Asia

Rest of Asia Pacific

Latin America

Brazil

Argentina

Rest of Latin America

Middle East & Africa

GCC Countries

South Africa

Rest of the Middle East and Africa

Browse the full report https://www.credenceresearch.com/report/deflectable-catheters-market

Contact:

Credence Research

Please contact us at +91 6232 49 3207

Email: sales@credenceresearch.com

Website: www.credenceresearch.com

[medicaldevicess]

Endoscopy Procedures Market: A Deep Dive

The rising trend of avoiding minimally invasive surgeries leads to the trend towards more endoscopy procedures. This report discusses the major growth drivers, emerging trends, and the future outlook in this rising sector.

Market Overview

The use of endoscopy procedures refers to the exploration of the human body's interior by using specialized equipment. Most such procedures are applied in diagnosis, treatment, and surgical interventions among patients receiving care in different specialties, including gastroenterology, pulmonology, urology, and gynecology. There is a high demand for this market owing to the rising incidence of chronic conditions among people, including gastrointestinal disorders, lung diseases, and urological conditions.

The market for endoscopy procedures was sized at US$ 30,877.37 million in 2022. It is expected to reach US$ 53,196.65 million by 2030. This market is anticipated to witness a CAGR of 7.0% during 2022-2030.

Prominent Market Drivers

Several factors are contributing to the growth of the endoscopy procedures market:

The steadily increasing incidence of diseases from both the digestive and respiratory systems today is driving the endoscopic procedures to diagnose and treat many conditions.

Emerging Technology: In addition, continuous technological advancement has allowed robotic-assisted endoscopy and capsule endoscopy, thereby providing for less invasive procedures with better precision and accuracy.

Aging Population: An aging population is prone to chronic disorders and is bound to increase the demand for endoscopic procedures.

Healthcare Spending: Increased healthcare spending in developed countries also contributes to the surge in the demand for endoscopic procedures.

Less Invasive Procedures: As an endoscopic procedure requires minimal incisions compared with open surgery, the former provides shorter recovery periods with less pain and lower risks of complications.

The present endoscopy procedures market is seeing many emerging trends that shape its future as follows:

Robotic-Assisted Endoscopy: Robotic-assisted endoscopy offers precision and flexibility in complex procedures with minimal invasiveness. Capsule Endoscopy: This is a minimally invasive technique to examine the small intestine without the use of sedation or anesthesia.

Artificial Intelligence (AI) and Machine Learning: AI-based devices are used to image an endoscopy and improve diagnosis and the precise decision on treatment planning.

Virtual Reality (VR) and Augmented Reality (AR): Currently, many researches are in progress to integrate VR and AR technologies for better training and experience of endoscopic operation.

Segments Covered

By Procedures

Endoscopic Retrograde Cholangiopancreatography

Endoscopic Submucosal Dissection

Peroral Endoscopic Myotomy

Endoscopic Ultrasound

By Offering

Endoscopes

ERCP Accessories

Endoscopic Ultrasound Guided Devices

Guidewire

By Product Type

Disposable

Reusable

By End User

Hospitals and Clinics

Ambulatory Surgical Centers

Diagnostic Laboratories

By Region

North America

Europe

Asia-Pacific

South and Central America

Middle East and Africa

Market leaders and key company profiles

Stryker Corp

Fujifilm Holdings Corp

Merit Medical Systems Inc

Smith & Nephew Plc

Arthrex Inc

Steris Plc

Conmed Corp

Olympus Corp

Boston Scientific Corp

Market Challenges

Although the growth prospects are quite attractive, the endoscopy procedures market suffers from the following challenges:

Expensive Procedures:- Advanced endoscopic procedures, such as robotic-assisted surgery, may be expensive and, therefore, not reach affordable people in a poor economy.

Risk of Complications- Although minimally invasive, the endoscopic procedures do carry inherent risks of infection and bleeding.

Regulatory Hurdles- Strict regulatory requirements can delay the introduction of new endoscopic technologies and medical devices.

Future Outlook

The endoscopy procedures market is expected to continue growing in the coming years. The improvements in technology, the increasing demand for minimally invasive procedures, and an aging population will drive market expansion. However, sustained growth hinges on addressing challenges that affect costs, access, and regulatory hurdles.

By keeping up with the emerging trends and technological advancement, healthcare providers and market participants can capture the opportunities offered through the endoscopy procedures market and lead the way further to patient outcomes.

Frequently Asked Questions-

What is the largest regional market for Endoscopy Procedures?

Ans: - North America is the largest regional market for Endoscopy Procedures.

Which are the leading companies to hold the market share in the Endoscopy Procedures market?

Ans: Top Companies: Stryker Corp; Fujifilm Holdings Corp, Merit Medical Systems Inc, Smith & Nephew Plc, Arthrex Inc, Steris Plc; Conmed Corp, Olympus Corp, Boston Scientific Corp, Cook Medical Llc are the top companies that hold the market share.

What would be the growth rate of the market during the forecast period from 2022 to 2030?

Ans: - The Endoscopy Procedures market is anticipated to expand at a CAGR of 7.0% between 2022 and 2030.

What is the size of the Endoscopy Procedures market?

Ans: - The global Endoscopy Procedures market size was at US$ 30,877.37 million in 2022 and is expected to reach US$ 53,196.65 million by 2030.

Which are the key segments of the Endoscopy Procedures market?

Ans: The Endoscopy Procedures Market is segmented by product, end-user, and geography.

About Us-

The Insight Partners is among the leading market research and consulting firms in the world. We take pride in delivering exclusive reports along with sophisticated strategic and tactical insights into the industry. Reports are generated through a combination of primary and secondary research, solely aimed at giving our clientele a knowledge-based insight into the market and domain. This is done to assist clients in making wiser business decisions. A holistic perspective in every study undertaken forms an integral part of our research methodology and makes the report unique and reliable.

[marketanalysisdata]

Urinary Catheters Industry Size, Share, Growth, Analysis Forecast to 2030

The global urinary catheters market was valued at USD 5.2 billion in 2022 and is anticipated to grow at a compound annual growth rate (CAGR) of 5.4% from 2023 to 2030. This growth is driven by an increasing number of patients experiencing Urinary Tract Infections (UTIs), urethral blockages, and tumors in the urinary tract or reproductive organs, along with the rapidly expanding geriatric population. Urinary catheters, which are flexible tubes used to drain urine from the bladder, are commonly made from materials such as plastic, rubber, and silicon. Physicians recommend urinary catheterization for conditions such as Urinary Incontinence (UI), urinary retention, prostate surgery, or other medical issues like spinal cord injury, multiple sclerosis, or dementia, where bladder function may be compromised.

Gather more insights about the market drivers, restrains and growth of the Urinary Catheters Market

Regional Insights:

North America Urinary Catheters Market Trends

North America led the global urinary catheters market in 2022, holding over 34.4% of the total revenue share, with expected continued growth. This dominance is attributed to the increasing prevalence of diseases such as bladder obstruction, UI, Benign Prostate Hyperplasia (BPH), urinary retention, and bladder cancer. In North America, urological conditions are a significant health concern, especially among the elderly. The National Association for Continence reports that individuals aged 40 and above frequently suffer from Overactive Bladder (OAB) and urine urgency. Additionally, the American Society of Nephrology notes that urologic issues rank as the third most common complaint in individuals aged 65 and above, accounting for about 47% of physician visits in the U.S. Furthermore, bladder cancer rates are significant; according to the Canadian Cancer Society, around 12,200 cases were diagnosed in 2020, with 2,600 related deaths. The high incidence of BPH-related surgeries and rising bladder cancer cases are key factors driving market growth in North America.

Asia Pacific Urinary Catheters Market Trends

The Asia Pacific region is projected to be the fastest-growing market for urinary catheters during the forecast period. This growth is fueled by the increasing incidence of spinal cord injuries, BPH, and UTIs, with UTIs being among the most prevalent infectious diseases in the region. UTIs in Asia Pacific lead to high rates of morbidity and mortality, especially in hospitals, and impose a considerable financial burden on communities. Factors like advancing age, constipation, vaginal deliveries, childbirth, obesity, surgery, and chronic respiratory conditions elevate the risk of UTIs, particularly among women, thereby driving demand for urinary catheters in the region. Additionally, increased government spending, investments by leading market players, and awareness initiatives are expected to contribute to market growth. For example, in India, the Urological Society of India developed guidelines to raise awareness about urinary incontinence, while in South Korea, the Korean Incontinence Society promotes awareness regarding pelvic floor and lower urinary tract health issues. Such initiatives are anticipated to drive market expansion in Asia Pacific throughout the forecast period.

Browse through Grand View Research's Category Medical Devices Industry Research Reports.

The global endoscope sterilization market size was estimated at USD 1.20 billion in 2024 and is projected to grow at a CAGR of 9.64% from 2025 to 2030.

The global neuromodulation devices market size was estimated at USD 5,795.81 million in 2024 and is anticipated to grow at a CAGR of 8.51% from 2025 to 2030.

Key Companies & Market Share Insights:

To expand their market share, companies in the urinary catheters industry are continuously introducing new products and expanding their geographical reach. For instance, Japan-based Terumo Corporation acquired Sequent Medical, a U.S.-based medical device manufacturer, through its U.S. subsidiary. This acquisition reflects a broader trend among global players, who are relocating production facilities to different countries to achieve economies of scale.

Furthermore, many manufacturers in the catheter industry form partnerships with major medical device distributors to supply their products either globally or within specific countries. Such strategic alliances are widespread and benefit manufacturers by providing marketing licenses, while also reducing liability in cases of product recall or adverse events. A prominent example is the three-year purchasing agreement signed in March 2019 between Coloplast Corporation and Premier Inc., a U.S.-based healthcare company. Through this agreement, Coloplast’s urology products, including catheters, gained access to Premier’s network alliance, which consists of around 4,000 U.S. hospitals. Premier's integrated supply chain, advisory, and data analytics solutions allow Coloplast to secure supply agreements at lower costs, supporting the company’s market presence and reach in the U.S.

Key Urinary Catheters Companies:

Hollister, Inc.

Medtronic PLC

Boston Scientific Corp.

BD (C.R. Bard, Inc.)

Cook Medical

ConvaTec, Inc.

Teleflex, Inc.

Coloplast

Braun Melsungen AG

Medline Industries, Inc.

J and M Urinary Catheters LLC

Order a free sample PDF of the Urinary Catheters Market Intelligence Study, published by Grand View Research.

[marketsndata]

Global Vascular Access Devices Market Assessment 2031

Global vascular access devices market is projected to witness a CAGR of 5.83% during the forecast period 2024-2031, growing from USD 3.63 billion in 2023 to USD 5.71 billion in 2031. With increasing disease burden, rising hospitalization, and an improved healthcare system, the market of vascular access devices is anticipated to expand at a notable pace during the forecast period.

Vascular access devices are insertions used to administer drugs, fluids, blood, and nutrients in blood vessels. These devices include peripherally inserted central catheters (PICCs), central venous catheters, implantable ports, and peripheral intravenous catheters (PIVCs). With the never-ending evolution of healthcare services and medical devices, vascular access devices have evolved in terms of design, material, and integration of imaging technologies in it. Advancements in vascular access devices have improved biocompatibility, flexibility, and the adoption of novel materials, enhancing patient outcomes and quality of life. The rising demand for vascular access devices is driven by the growing burden of lifestyle diseases, technological advancements, and the need for minimally invasive procedures. Manufacturers are consistently working to enhance device design and materials to improve patient outcomes and reduce complications.

For instance, in May 2024, Teleflex Incorporated launched the Arrow EZ-IO Intraosseous Access Procedure Tray, enhancing its intraosseous vascular access portfolio. It includes all necessary components for intraosseous access, featuring the first FDA-cleared battery-powered driver that can be utilized in sterile environments. The tray is designed for quick and precise insertion, addressing the challenges clinicians face in obtaining vascular access during emergencies. However, risks associated with long-term use of catheters, such as infections and sepsis may pose challenges for market growth.

Rising Burden of Chronic Diseases to Increase the Market Size

The chronic disease burden is on a rise globally, owing to the increasing prevalence of chronic diseases, such as cancer, cardiovascular and urological disorders, and others, which necessitates frequent and long-term vascular access for treatments such as chemotherapy, dialysis, and medication administration, thereby driving the demand for various types of vascular access devices, including central venous catheters and peripheral IV catheters. Another factor contributing to the growing burden is the rising geriatric population, highly prone to catching such diseases. With the ongoing scenario, the future demand for vascular access devices is anticipated to increase further.

For instance, the National Institute of Health (NIH), anticipates that the number of adults 50 years and older suffer from at least one chronic disease, which will increase by 99.5% from 71.522 million in 2020 to 142.66 million in 2050. An estimated 48 million people, or 47% of all deaths globally, are expected to die from severe health-related suffering by 2060, an 87% increase from 26 million in 2016. It is anticipated that 83% of these deaths will occur in low and middle-income countries. As per World Health Organization (WHO) estimates, by 2050, there will be twice as many people 60 years or older on the planet with the population of 2.1 billion.

Design Improvements to Drive Market Demand

The established types of vascular access devices include central venous catheters (CVCs), arteriovenous fistulas (AVFs), and arteriovenous grafts (AVGs). Innovations in CVC tip and coating design have improved patency and blood flow rates. AVFs are preferred over CVCs as they are less prone to clotting and infection while providing reliable and adequate blood flow rates. With such design enhancements, the AVF creation devices have significant traction leading to market growth. Market players are taking chances to launch innovative products with enhanced designs. For instance, in September 2023, Laminate Medical Technologies announced that it received US-FDA clearance for its VasQ External Vascular Support device, designed to create AVFs for dialysis access. Notably, 80% of patients in trials using VasQ were able to remove central venous catheters within their first year of treatment, reducing the risk of infection compared to traditional AVFs. The VasQ device provides structural reinforcement to the vessels during AVF creation, promoting better arterial flow and functionality.

Drug Administration Application to Dominate Vascular Access Devices Market Share

The drug administration application of the vascular access devices market is anticipated to cover the highest market share. As these devices provide reliable, long-term access to the bloodstream, which is essential for patients needing frequent or prolonged intravenous therapies, such as chemotherapy or chronic disease management, reducing complications associated with traditional IV lines, such as infections and vein irritation, by minimizing the need for repeated needle sticks. A recent study published in the British Medical Journal in July 2024 examined the effectiveness of vascular access devices (VADs) in reducing infection rates among hospitalized patients. The study concluded that VADs along with specific safety measures reduce the chances of infection.

Download Free Sample Report

North America Dominates the Global Vascular Access Devices Market Share

North America is anticipated to hold major market share of the global vascular access devices market. North America’s leadership in the demand for vascular access devices is attributed to its advanced healthcare infrastructure, rising prevalence of chronic diseases, technological innovations, supportive regulations, and demographic trends favoring increased healthcare needs. According to the United States Renal Data System 2023 Annual Data Report, published in April 2024, more than 85% of individuals who began hemodialysis used a catheter. Additionally, nearly three-quarters of the United States population started without permanent access, a significant increase from about 65% in 2018. This rise in number clearly shows an increasing consumption of such devices in North America causing it to hold the largest market share among other regions.

Future Market Scenario (2024 – 2031F)

The vascular access devices market has witnessed several remarkable futuristic advancements that are anticipated to shape the future of such devices. These advancements include wearable technology, remote monitoring of atrioventricular flow, use of biocompatible materials for product design, 3D printing technology, image-guided vascular access devices, and others. The USFDA approval of WavelinQ and Ellipsys, two vascular access devices that facilitate the creation of arteriovenous fistulas (AVFs) using minimally invasive techniques has paved a new path for more products in line with endovascular fistula creation. The of the most revolutionary advancement is the image-guided vascular access system, Ultreon 1.0 launched by Abbott in October 2023. This platform uses near-infrared light to provide high-definition, precise imaging from within the blood vessels, allowing the healthcare professional precise access to blood vessels even in the most complex anatomies.

Report Scope

“Vascular Access Devices Market Assessment, Opportunities and Forecast, 2017-2031F”, is a comprehensive report by Markets and Data, providing in-depth analysis and qualitative and quantitative assessment of the current state of global vascular access devices market, industry dynamics, and challenges. The report includes market size, segmental shares, growth trends, opportunities, and forecast between 2024 and 2031. Additionally, the report profiles the leading players in the industry, mentioning their respective market share, business models, competitive intelligence, etc.

Click here for full report- https://www.marketsandata.com/industry-reports/vascular-access-devices-market

Latest reports-

Contact

Mr. Vivek Gupta 5741 Cleveland street, Suite 120, VA beach, VA, USA 23462 Tel: +1 (757) 343–3258 Email: info@marketsandata.com Website: https://www.marketsandata.com

[marketstudyreport]

Urinary Catheters Industry Segmentation, Parameters and Prospects by 2030

The global urinary catheters market was valued at USD 5.2 billion in 2022 and is anticipated to grow at a compound annual growth rate (CAGR) of 5.4% from 2023 to 2030. This growth is driven by an increasing number of patients experiencing Urinary Tract Infections (UTIs), urethral blockages, and tumors in the urinary tract or reproductive organs, along with the rapidly expanding geriatric population. Urinary catheters, which are flexible tubes used to drain urine from the bladder, are commonly made from materials such as plastic, rubber, and silicon. Physicians recommend urinary catheterization for conditions such as Urinary Incontinence (UI), urinary retention, prostate surgery, or other medical issues like spinal cord injury, multiple sclerosis, or dementia, where bladder function may be compromised.

Gather more insights about the market drivers, restrains and growth of the Urinary Catheters Market

Regional Insights:

North America Urinary Catheters Market Trends

North America led the global urinary catheters market in 2022, holding over 34.4% of the total revenue share, with expected continued growth. This dominance is attributed to the increasing prevalence of diseases such as bladder obstruction, UI, Benign Prostate Hyperplasia (BPH), urinary retention, and bladder cancer. In North America, urological conditions are a significant health concern, especially among the elderly. The National Association for Continence reports that individuals aged 40 and above frequently suffer from Overactive Bladder (OAB) and urine urgency. Additionally, the American Society of Nephrology notes that urologic issues rank as the third most common complaint in individuals aged 65 and above, accounting for about 47% of physician visits in the U.S. Furthermore, bladder cancer rates are significant; according to the Canadian Cancer Society, around 12,200 cases were diagnosed in 2020, with 2,600 related deaths. The high incidence of BPH-related surgeries and rising bladder cancer cases are key factors driving market growth in North America.

Asia Pacific Urinary Catheters Market Trends

The Asia Pacific region is projected to be the fastest-growing market for urinary catheters during the forecast period. This growth is fueled by the increasing incidence of spinal cord injuries, BPH, and UTIs, with UTIs being among the most prevalent infectious diseases in the region. UTIs in Asia Pacific lead to high rates of morbidity and mortality, especially in hospitals, and impose a considerable financial burden on communities. Factors like advancing age, constipation, vaginal deliveries, childbirth, obesity, surgery, and chronic respiratory conditions elevate the risk of UTIs, particularly among women, thereby driving demand for urinary catheters in the region. Additionally, increased government spending, investments by leading market players, and awareness initiatives are expected to contribute to market growth. For example, in India, the Urological Society of India developed guidelines to raise awareness about urinary incontinence, while in South Korea, the Korean Incontinence Society promotes awareness regarding pelvic floor and lower urinary tract health issues. Such initiatives are anticipated to drive market expansion in Asia Pacific throughout the forecast period.

Browse through Grand View Research's Category Medical Devices Industry Research Reports.

The global endoscope sterilization market size was estimated at USD 1.20 billion in 2024 and is projected to grow at a CAGR of 9.64% from 2025 to 2030.

The global neuromodulation devices market size was estimated at USD 5,795.81 million in 2024 and is anticipated to grow at a CAGR of 8.51% from 2025 to 2030.

Key Companies & Market Share Insights:

To expand their market share, companies in the urinary catheters industry are continuously introducing new products and expanding their geographical reach. For instance, Japan-based Terumo Corporation acquired Sequent Medical, a U.S.-based medical device manufacturer, through its U.S. subsidiary. This acquisition reflects a broader trend among global players, who are relocating production facilities to different countries to achieve economies of scale.

Furthermore, many manufacturers in the catheter industry form partnerships with major medical device distributors to supply their products either globally or within specific countries. Such strategic alliances are widespread and benefit manufacturers by providing marketing licenses, while also reducing liability in cases of product recall or adverse events. A prominent example is the three-year purchasing agreement signed in March 2019 between Coloplast Corporation and Premier Inc., a U.S.-based healthcare company. Through this agreement, Coloplast’s urology products, including catheters, gained access to Premier’s network alliance, which consists of around 4,000 U.S. hospitals. Premier's integrated supply chain, advisory, and data analytics solutions allow Coloplast to secure supply agreements at lower costs, supporting the company’s market presence and reach in the U.S.

Key Urinary Catheters Companies:

Hollister, Inc.

Medtronic PLC

Boston Scientific Corp.

BD (C.R. Bard, Inc.)

Cook Medical

ConvaTec, Inc.

Teleflex, Inc.

Coloplast

Braun Melsungen AG

Medline Industries, Inc.

J and M Urinary Catheters LLC

Order a free sample PDF of the Urinary Catheters Market Intelligence Study, published by Grand View Research.